327 related articles for article (PubMed ID: 20704563)
1. Characterization of PF-4708671, a novel and highly specific inhibitor of p70 ribosomal S6 kinase (S6K1).
Pearce LR; Alton GR; Richter DT; Kath JC; Lingardo L; Chapman J; Hwang C; Alessi DR
Biochem J; 2010 Oct; 431(2):245-55. PubMed ID: 20704563
[TBL] [Abstract][Full Text] [Related]
2. Phosphorylation of IRS1 at serine 307 in response to insulin in human adipocytes is not likely to be catalyzed by p70 ribosomal S6 kinase.
Rajan MR; Fagerholm S; Jönsson C; Kjølhede P; Turkina MV; Strålfors P
PLoS One; 2013; 8(4):e59725. PubMed ID: 23565163
[TBL] [Abstract][Full Text] [Related]
3. Inhibition of mitochondrial complex 1 by the S6K1 inhibitor PF-4708671 partly contributes to its glucose metabolic effects in muscle and liver cells.
Shum M; Houde VP; Bellemare V; Junges Moreira R; Bellmann K; St-Pierre P; Viollet B; Foretz M; Marette A
J Biol Chem; 2019 Aug; 294(32):12250-12260. PubMed ID: 31243102
[TBL] [Abstract][Full Text] [Related]
4. p70 S6K1 nuclear localization depends on its mTOR-mediated phosphorylation at T389, but not on its kinase activity towards S6.
Rosner M; Schipany K; Hengstschläger M
Amino Acids; 2012 Jun; 42(6):2251-6. PubMed ID: 21710263
[TBL] [Abstract][Full Text] [Related]
5. PF-4708671 activates AMPK independently of p70S6K1 inhibition.
Vainer GW; Saada A; Kania-Almog J; Amartely A; Bar-Tana J; Hertz R
PLoS One; 2014; 9(9):e107364. PubMed ID: 25202971
[TBL] [Abstract][Full Text] [Related]
6. Pharmacological inhibition of S6K1 increases glucose metabolism and Akt signalling in vitro and in diet-induced obese mice.
Shum M; Bellmann K; St-Pierre P; Marette A
Diabetologia; 2016 Mar; 59(3):592-603. PubMed ID: 26733005
[TBL] [Abstract][Full Text] [Related]
7. mTORC1-activated S6K1 phosphorylates Rictor on threonine 1135 and regulates mTORC2 signaling.
Julien LA; Carriere A; Moreau J; Roux PP
Mol Cell Biol; 2010 Feb; 30(4):908-21. PubMed ID: 19995915
[TBL] [Abstract][Full Text] [Related]
8. A new tool to dissect the function of p70 S6 kinase.
Bilanges B; Vanhaesebroeck B
Biochem J; 2010 Oct; 431(2):e1-3. PubMed ID: 20874709
[TBL] [Abstract][Full Text] [Related]
9. p90 ribosomal S6 kinase and p70 ribosomal S6 kinase link phosphorylation of the eukaryotic chaperonin containing TCP-1 to growth factor, insulin, and nutrient signaling.
Abe Y; Yoon SO; Kubota K; Mendoza MC; Gygi SP; Blenis J
J Biol Chem; 2009 May; 284(22):14939-48. PubMed ID: 19332537
[TBL] [Abstract][Full Text] [Related]
10. PF-4708671, a specific inhibitor of p70 ribosomal S6 kinase 1, activates Nrf2 by promoting p62-dependent autophagic degradation of Keap1.
Park JS; Kang DH; Lee DH; Bae SH
Biochem Biophys Res Commun; 2015 Oct; 466(3):499-504. PubMed ID: 26381178
[TBL] [Abstract][Full Text] [Related]
11. Peroxisome proliferator-activated receptor-gamma and retinoic acid X receptor alpha represses the TGFbeta1 gene via PTEN-mediated p70 ribosomal S6 kinase-1 inhibition: role for Zf9 dephosphorylation.
Lee SJ; Yang EK; Kim SG
Mol Pharmacol; 2006 Jul; 70(1):415-25. PubMed ID: 16611854
[TBL] [Abstract][Full Text] [Related]
12. Characterization of GSK2334470, a novel and highly specific inhibitor of PDK1.
Najafov A; Sommer EM; Axten JM; Deyoung MP; Alessi DR
Biochem J; 2011 Jan; 433(2):357-69. PubMed ID: 21087210
[TBL] [Abstract][Full Text] [Related]
13. Two widely used RSK inhibitors, BI-D1870 and SL0101, alter mTORC1 signaling in a RSK-independent manner.
Roffé M; Lupinacci FC; Soares LC; Hajj GN; Martins VR
Cell Signal; 2015 Aug; 27(8):1630-42. PubMed ID: 25889895
[TBL] [Abstract][Full Text] [Related]
14. The mTOR Substrate S6 Kinase 1 (S6K1) Is a Negative Regulator of Axon Regeneration and a Potential Drug Target for Central Nervous System Injury.
Al-Ali H; Ding Y; Slepak T; Wu W; Sun Y; Martinez Y; Xu XM; Lemmon VP; Bixby JL
J Neurosci; 2017 Jul; 37(30):7079-7095. PubMed ID: 28626016
[TBL] [Abstract][Full Text] [Related]
15. Chronic inhibition of the mTORC1/S6K1 pathway increases insulin-induced PI3K activity but inhibits Akt2 and glucose transport stimulation in 3T3-L1 adipocytes.
Veilleux A; Houde VP; Bellmann K; Marette A
Mol Endocrinol; 2010 Apr; 24(4):766-78. PubMed ID: 20203102
[TBL] [Abstract][Full Text] [Related]
16. Cross-talk between sirtuin and mammalian target of rapamycin complex 1 (mTORC1) signaling in the regulation of S6 kinase 1 (S6K1) phosphorylation.
Hong S; Zhao B; Lombard DB; Fingar DC; Inoki K
J Biol Chem; 2014 May; 289(19):13132-41. PubMed ID: 24652283
[TBL] [Abstract][Full Text] [Related]
17. Contribution of S6K1/MAPK signaling pathways in the response to oxidative stress: activation of RSK and MSK by hydrogen peroxide.
Siebel A; Cubillos-Rojas M; Santos RC; Schneider T; Bonan CD; Bartrons R; Ventura F; Rodrigues de Oliveira J; Rosa JL
PLoS One; 2013; 8(9):e75523. PubMed ID: 24058693
[TBL] [Abstract][Full Text] [Related]
18. Resistance to Selumetinib (AZD6244) in colorectal cancer cell lines is mediated by p70S6K and RPS6 activation.
Grasso S; Tristante E; Saceda M; Carbonell P; Mayor-López L; Carballo-Santana M; Carrasco-García E; Rocamora-Reverte L; García-Morales P; Carballo F; Ferragut JA; Martínez-Lacaci I
Neoplasia; 2014 Oct; 16(10):845-60. PubMed ID: 25379021
[TBL] [Abstract][Full Text] [Related]
19. Inhibition of p70 S6 kinase (S6K1) activity by A77 1726 and its effect on cell proliferation and cell cycle progress.
Doscas ME; Williamson AJ; Usha L; Bogachkov Y; Rao GS; Xiao F; Wang Y; Ruby C; Kaufman H; Zhou J; Williams JW; Li Y; Xu X
Neoplasia; 2014 Oct; 16(10):824-34. PubMed ID: 25379019
[TBL] [Abstract][Full Text] [Related]
20. Muscarinic receptor-mediated activation of p70 S6 kinase 1 (S6K1) in 1321N1 astrocytoma cells: permissive role of phosphoinositide 3-kinase.
Tang X; Wang L; Proud CG; Downes CP
Biochem J; 2003 Aug; 374(Pt 1):137-43. PubMed ID: 12747804
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
